IPO Trending
MAHALIFESME / BSEListed

Mahamaya Lifesciences Limited

Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in the manufacturing, registration, and export of high-quality crop protection products and bioproducts designed to enhance soil and crop health. The company specializes in pesticide formulations and supplies bulk products to leading Indian agrochemical players as well as multinational corporations (MNCs). Mahamaya imports global research-based molecules, registers them with the Central Insecticides Board, and markets both technical and value-added formulations. The company has invested significantly in global registrations and currently exports to markets such as the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey. Its portfolio spans bulk formulations, technical grade molecules, branded products, and export-focused formulations.

₹108 - ₹1141.71x sub
Listed Price116.00
Listing Gain+1.75%
TimelineBookbuilding IPO
Open11 Nov 2025
Close13 Nov 2025
Allotment14 Nov 2025
Listing18 Nov 2025

Quota Reservation Portions

AnchorPortion: 17,52,000 shares
28.36%
QIBPortion: 11,76,000 shares
19.03%
HNIPortion: 8,82,000 shares
14.27%
RetailPortion: 20,59,200 shares
33.33%
Market MakerPortion: 3,09,600 shares
5.01%

Minimum Application Bracket Matrix

Retail2 lots / 2,400 shares
₹2,73,600
sHNI3 lots / 3,600 shares
₹4,10,400
bHNI8 lots / 9,600 shares
₹10,94,400

About the Company

Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in the manufacturing, registration, and export of high-quality crop protection products and bioproducts designed to enhance soil and crop health. The company specializes in pesticide formulations and supplies bulk products to leading Indian agrochemical players as well as multinational corporations (MNCs). Mahamaya imports global research-based molecules, registers them with the Central Insecticides Board, and markets both technical and value-added formulations. The company has invested significantly in global registrations and currently exports to markets such as the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey. Its portfolio spans bulk formulations, technical grade molecules, branded products, and export-focused formulations.

Company Promoters

Mr. Krishnamurthy GanesanMrs. Lalitha KrishnamurthyMr. Prashant Krishnamurthy
Mahamaya Lifesciences Limited IPO Details | GMP, Allotment & Financials | IPO Trending